BRCA2 and breast cancer: The mean age at diagnosis of BC in patients with BRCA2 c.1310_1313 DelAAGA mutation was 38.5 years (SD = 8.92, range: 28–54) with a large proportion (60%) diagnosed at 39 years of age or younger compared to noncarriers (37%).